Lesson of the Week Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity

被引:11
|
作者
Wee, Jamie S.
Marinaki, Anthony
Smith, Catherine H.
机构
[1] St. Thomas' Hospital
来源
BRITISH MEDICAL JOURNAL | 2011年 / 342卷
关键词
INFLAMMATORY-BOWEL-DISEASE; S-METHYLTRANSFERASE; MYELOSUPPRESSION; PHARMACOGENETICS; THERAPY;
D O I
10.1136/bmj.d1417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:762 / 764
页数:3
相关论文
共 10 条
  • [1] Relationship between red blood cell thiopurine methyltransferase activity and myelotoxicity in dogs receiving azathioprine
    Rodriguez, DB
    Mackin, A
    Easley, R
    Boyle, CR
    Hou, WY
    Langston, C
    Walsh, AM
    Province, MA
    McLeod, HL
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2004, 18 (03): : 339 - 345
  • [2] Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial
    Meggitt, SJ
    Gray, JC
    Reynolds, NJ
    LANCET, 2006, 367 (9513): : 839 - 846
  • [3] Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression
    Leung, M.
    Piatkov, I.
    Rochester, C.
    Boyages, S. C.
    Leong, R. W. L.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (02) : 121 - 126
  • [4] A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression
    Murphy, LA
    Atherton, D
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 308 - 315
  • [5] Parallel-group, randomized controlled trial of azathioprine in moderate to severe atopic eczema, using a thiopurine methyltransferase-based dose regimen
    Meggitt, SJ
    Gray, JC
    Reynolds, NJ
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 3 - 3
  • [6] Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature
    Yeter, K. C.
    Afkhami, M.
    Brynes, R. K.
    Quismorio, F. P., Jr.
    LUPUS, 2013, 22 (14) : 1526 - 1528
  • [7] Safety of Azathioprine Therapy Adjusted to Thiopurine Methyltransferase Activity in the Treatment of Infantile Atopic Dermatitis. Report on 7 Cases
    Martel, R. M.
    Melwani, P.
    Islas, D.
    Penate, Y.
    Borrego, L.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (05): : 415 - 420
  • [8] Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease
    Jonason, David E.
    Sievers, Tyson
    Trocke, Lindsay
    Abraham, James M.
    Vaughn, Byron P.
    CROHNS & COLITIS 360, 2020, 2 (03) : 1 - 7
  • [9] AZATHIOPRINE HAEMATOTOXICITY DUE TO LOW THIOPURINE METHYLTRANSFERASE ACTIVITY AND XANTHINE-OXIDASE DEFICIENCY IN A RENAL-TRANSPLANTATION PATIENT
    SERREDEBEAUVAIS, F
    BAYLE, F
    AMIROU, M
    BECHTEL, Y
    BOUJET, C
    VIALTEL, P
    BESSARD, G
    PRESSE MEDICALE, 1995, 24 (21): : 987 - 988
  • [10] Anagen Effluvium due to Azathioprine in a Patient With Normal Thiopurine S-Methyltransferase Levels: A Case Report Using Videodermoscopic Analysis
    Shah Swapnil
    Ankad Balachandra S.
    Rajagopal Tanuja
    国际皮肤性病学杂志(英文), 2023, 06 (04)